The Calmer Co. reports strong sales growth

The Calmer Co. International (ASX:CCO) announced its Appendix 4C Cash Flow Statement and Quarterly Activities Report for the quarter ending September 30, 2024. The company reported record sales of $2.3 million, a 28% increase from the previous quarter and a 354% rise from the same period last year. The growth was largely driven by the Australian market and partnerships like Coles Australia.

Summary of The Calmer Co.'s strategic moves and future plans

The Calmer Co. International has reported significant growth in its latest quarterly activities, with a 28% increase in sales compared to the previous quarter, largely thanks to its strong position in the Australian market. The company is focusing on expanding its presence in the US, evidenced by increased marketing efforts and plans to launch new products such as kava tinctures. The upcoming facility upgrades and the potential acquisition of the Navua facility reflect its commitment to enhancing production capacity. Although faced with challenges like stock issues and the need for financial backing, the company is strategically positioning itself for sustained growth. Future plans include securing debt funding from the Fiji Development Bank and encouraging option conversion to fund acquisitions and meet working capital needs.

Executive commentary on quarterly performance

CEO Anthony Noble highlighted the company's strategic expansion and production capacity enhancements to meet growing demand. The marketing team is also working on introducing new products, including an updated Taki Mai brand with new formats like kava tinctures, which are set to launch in the US market.